中国临床保健杂志
中國臨床保健雜誌
중국림상보건잡지
Chinese Journal of Clinical Healthcare
2015年
5期
468-471
,共4页
丁宇%司全金%陆蔷蔷%徐昆%王海军%李开亮%张帷
丁宇%司全金%陸薔薔%徐昆%王海軍%李開亮%張帷
정우%사전금%륙장장%서곤%왕해군%리개량%장유
心血管疾病%脂肪族醇类%血小板聚集%动脉粥样硬化%老年人
心血管疾病%脂肪族醇類%血小闆聚集%動脈粥樣硬化%老年人
심혈관질병%지방족순류%혈소판취집%동맥죽양경화%노년인
Cardiovascular diseases%Fatty alcohols%Platelet aggregation%Atherosclerosis%Aged
目的研究多廿烷醇在老年心血管疾病患者中调脂作用外的多效性作用。方法入选老年血脂异常患者共294例,随机将入选患者分4组,多廿烷醇20 mg组(A组,n=64)、多廿烷醇10 mg组(B组,n=72)、阿托伐他汀20 mg组(C组,n=91)、多廿烷醇10 mg+阿托伐他汀20 mg组(D组,n=62)。所有患者分别于试验开始前、试验第12周、24周、52周时,测定其血小板计数、血小板聚集率、循环内皮细胞( CECs)计数、超敏C反应蛋白( hs-CRP)、颈动脉内膜中层厚度( IMT)等。结果 A组治疗后二磷酸腺苷( ADP)诱导的血小板聚集率较治疗前有较明显降低[(48.79±20.29)%比(40.37±23.56)%],差异有统计学意义(P<0.05),但花生四烯酸(AA)诱导的血小板聚集率差异无统计学意义。 B组、C组和D组的AA 及ADP诱导的血小板聚集率均差异无统计学意义。各组CECs、hs-CRP、同型半胱氨酸治疗后均较治疗前降低,差异有统计学意义(P<0.05),但颈动脉IMT在各组治疗前后均差异无统计学意义。结论多廿烷醇除可调节血脂水平外,还有一定的改善内皮细胞功能及抗动脉粥样硬化作用。
目的研究多廿烷醇在老年心血管疾病患者中調脂作用外的多效性作用。方法入選老年血脂異常患者共294例,隨機將入選患者分4組,多廿烷醇20 mg組(A組,n=64)、多廿烷醇10 mg組(B組,n=72)、阿託伐他汀20 mg組(C組,n=91)、多廿烷醇10 mg+阿託伐他汀20 mg組(D組,n=62)。所有患者分彆于試驗開始前、試驗第12週、24週、52週時,測定其血小闆計數、血小闆聚集率、循環內皮細胞( CECs)計數、超敏C反應蛋白( hs-CRP)、頸動脈內膜中層厚度( IMT)等。結果 A組治療後二燐痠腺苷( ADP)誘導的血小闆聚集率較治療前有較明顯降低[(48.79±20.29)%比(40.37±23.56)%],差異有統計學意義(P<0.05),但花生四烯痠(AA)誘導的血小闆聚集率差異無統計學意義。 B組、C組和D組的AA 及ADP誘導的血小闆聚集率均差異無統計學意義。各組CECs、hs-CRP、同型半胱氨痠治療後均較治療前降低,差異有統計學意義(P<0.05),但頸動脈IMT在各組治療前後均差異無統計學意義。結論多廿烷醇除可調節血脂水平外,還有一定的改善內皮細胞功能及抗動脈粥樣硬化作用。
목적연구다입완순재노년심혈관질병환자중조지작용외적다효성작용。방법입선노년혈지이상환자공294례,수궤장입선환자분4조,다입완순20 mg조(A조,n=64)、다입완순10 mg조(B조,n=72)、아탁벌타정20 mg조(C조,n=91)、다입완순10 mg+아탁벌타정20 mg조(D조,n=62)。소유환자분별우시험개시전、시험제12주、24주、52주시,측정기혈소판계수、혈소판취집솔、순배내피세포( CECs)계수、초민C반응단백( hs-CRP)、경동맥내막중층후도( IMT)등。결과 A조치료후이린산선감( ADP)유도적혈소판취집솔교치료전유교명현강저[(48.79±20.29)%비(40.37±23.56)%],차이유통계학의의(P<0.05),단화생사희산(AA)유도적혈소판취집솔차이무통계학의의。 B조、C조화D조적AA 급ADP유도적혈소판취집솔균차이무통계학의의。각조CECs、hs-CRP、동형반광안산치료후균교치료전강저,차이유통계학의의(P<0.05),단경동맥IMT재각조치료전후균차이무통계학의의。결론다입완순제가조절혈지수평외,환유일정적개선내피세포공능급항동맥죽양경화작용。
Objective To comparatively observe Policosanol’ s multi effects beyond lipid lowering in the eld-erlypatientswithcardiovasculardiseases.Methods 294elderlypatientswithdyslipidemiawereincluded.Allpa-tients were randomly divided into four groups:policosanol 20 mg group ( group A,n=64); Policosanol 10mg group (group B,n=72);atorvastatin 20mg group (group C,n=91);policosanol 10mg +atorvastatin 20mg group(group D,n=62).The following indexes were observed at 0d,12th week,24th week and 52th week: platelet counts,platelet aggregation rates,CECs,and carotid artery intima-media thickness.Results ADP induced platelet aggregation rate was decreased significantly in group A when compared with the baseline [(48.79 ±20.29)% vs.(40.37 ± 23.56)%],but AA induced platelet aggregation rate was not.Both AA and ADP induced Platelet aggregation rates had no significant changes in other groups.CECs,hs-CRP and Hcy levels were all decreased significantly at 52th week after treatment in each group.There was no statistical change of IMT in each group after treatment.Conclusions Besides lipid modulating effects,policosanol also had other effects such as improving endothelial functions and preventing pro-gression of atherosclerosis.